Novartis Neoral Patient Assistance Proposal Violates Kickback Laws, IG Says
Executive Summary
Novartis will have to work through a third party if it wants to proceed with a program to help low-income Medicare patients afford their portion of costs for the cyclosporine products Neoral and Sandimmune
You may also be interested in...
PhRMA Patient Assistance Website Will Simplify Eligibility Determinations
The Pharmaceutical Research & Manufacturers of America is launching an online verification system for its member companies' patient assistance programs
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011